Challenges in diagnosing head and neck cancer in primary health care.


Journal

Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 5 8 2020
medline: 22 9 2021
entrez: 5 8 2020
Statut: ppublish

Résumé

Early diagnosis of head and neck cancer (HNC) will improve patient outcomes. The low incidence of HNC renders its detection challenging for a general practitioner (GP) in primary health care (PHC). To examine these challenges, our cohort consisted of all patients visiting PHC centres in the City of Helsinki in 2016. We chose 57 ICD-10 codes representing a sign or symptom resulting from a possible HNC and compared data for all new HNC patients. A total of 242,211 patients (499,542 appointments) visited PHC centres, 11,896 (5%) of whom presented with a sign or symptom possibly caused by HNC. Altogether, 111 new HNCs were diagnosed within the Helsinki area, of which 40 (36%) were referred from PHC. The median delay from the initial PHC visit to the referral to specialist care was 5 days, whereby 88% of patients were referred within one month. Despite the low incidence of HNC and the large number of patients presenting with HNC-related symptoms, GPs working in PHC sort out potential HNC patients from the general patient group in most cases remarkably effectively. KEY MESSAGES For every head and neck cancer (HNC) patient encountered in the primary health care, a general practitioner (GP) will meet approximately 6000 other patients, 100 of whom exhibit a sign or a symptom potentially caused by a HNC. Despite the low incidence of HNC, GPs referred patients to specialist care effectively, limiting the median delay from the initial appointment to referral to only 5 days.

Sections du résumé

BACKGROUND
Early diagnosis of head and neck cancer (HNC) will improve patient outcomes. The low incidence of HNC renders its detection challenging for a general practitioner (GP) in primary health care (PHC).
PATIENTS AND METHODS
To examine these challenges, our cohort consisted of all patients visiting PHC centres in the City of Helsinki in 2016. We chose 57 ICD-10 codes representing a sign or symptom resulting from a possible HNC and compared data for all new HNC patients.
RESULTS
A total of 242,211 patients (499,542 appointments) visited PHC centres, 11,896 (5%) of whom presented with a sign or symptom possibly caused by HNC. Altogether, 111 new HNCs were diagnosed within the Helsinki area, of which 40 (36%) were referred from PHC. The median delay from the initial PHC visit to the referral to specialist care was 5 days, whereby 88% of patients were referred within one month.
CONCLUSIONS
Despite the low incidence of HNC and the large number of patients presenting with HNC-related symptoms, GPs working in PHC sort out potential HNC patients from the general patient group in most cases remarkably effectively. KEY MESSAGES For every head and neck cancer (HNC) patient encountered in the primary health care, a general practitioner (GP) will meet approximately 6000 other patients, 100 of whom exhibit a sign or a symptom potentially caused by a HNC. Despite the low incidence of HNC, GPs referred patients to specialist care effectively, limiting the median delay from the initial appointment to referral to only 5 days.

Identifiants

pubmed: 32746635
doi: 10.1080/07853890.2020.1802060
pmc: PMC7877942
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-33

Références

Otolaryngol Head Neck Surg. 1997 Feb;116(2):201-8
pubmed: 9051065
Allergy Asthma Proc. 2019 Jan 14;40(1):48-56
pubmed: 30582496
Br Dent J. 2016 May 27;220(10):521-6
pubmed: 27228932
Br J Gen Pract. 2019 Feb;69(679):e112-e126
pubmed: 30455220
Radiother Oncol. 2003 Mar;66(3):271-6
pubmed: 12742266
CMAJ. 2006 Mar 14;174(6):779-84
pubmed: 16534084
Acta Oncol. 2018 Dec;57(12):1677-1686
pubmed: 30141700
Cancer. 2001 Dec 1;92(11):2885-91
pubmed: 11753962
Br J Oral Maxillofac Surg. 2016 Feb;54(2):208-12
pubmed: 26682494
BMC Cancer. 2016 Jul 12;16:456
pubmed: 27406036
J Clin Oncol. 2016 Jan 10;34(2):169-78
pubmed: 26628469
J Voice. 2019 Nov;33(6):900-905
pubmed: 30126692
Oral Oncol. 2015 Mar;51(3):272-8
pubmed: 25541458
Clin Otolaryngol. 2008 Aug;33(4):325-30
pubmed: 18983341

Auteurs

Markus Nieminen (M)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Katri Aro (K)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Antti Mäkitie (A)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Clinical Sciences, Intervention and Technology, Division of Ear, Nose and Throat Diseases, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Vappu Harlin (V)

Department of Social Services and Health Care, City of Helsinki, Helsinki, Finland.

Satu Kainulainen (S)

Department of Oral and Maxillofacial Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Lauri Jouhi (L)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Timo Atula (T)

Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH